William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
National General (NGHC) Announces 5M Share Offering of Common Stock
-
National General Holdings Corp. Announces Offering of Common Stock
-
National General Holdings Corp. Announces Offering of Common Stock
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Sep 30
-
Gladstone Capital Corporation Announces Exercise and Closing of Over-Allotment Option for Notes due 2023
-
Gladstone Capital Corporation Announces Exercise and Closing of Over-Allotment Option for Notes due 2023
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Sep 30
-
Castlight Health to Participate in Upcoming Investor Conferences
-
William Blair Starts LogicBio Therapeutics (LOGC) at Outperform
-
PPC Partners to Acquire Plaskolite, A Leading Provider of Transparent Thermoplastic Sheet Products
-
Ceridian HCM Holding Inc. (CDAY) Announces Proposed 11M Share Secondary Offering
-
Sarepta Therapeutics (SRPT) Prices 3.187M Share Common Offering at $131/Sh
-
William Blair Downgrades Redfin Corp. (RDFN) to Market Perform
-
Sarepta Therapeutics Announces Pricing of $500,000,000 Public Offering of Common Stock
-
Albireo to Present at Investor Conferences in November
-
William Blair Downgrades Audentes Therapeutics (BOLD) to Market Perform
-
4D Molecular Therapeutics to Participate at Upcoming Investor Conferences
-
William Blair Downgrades ConvergeOne, Inc. (CVON) to Market Perform After Company Acquired by CVC Fund VII for $1.8 Billion
-
ConvergeOne (CVON) to be Acquired by CVC Fund VII for $1.8 Billion
-
ConvergeOne Agrees to be Acquired by CVC Fund VII for $1.8 Billion
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
OMERS Private Equity Announces Agreement to Sell MatrixCare to ResMed
-
William Blair Resumes Repligen (RGEN) at Outperform
-
Gladstone Capital Corporation Announces Offering of 6.125% Notes due 2023
-
Gladstone Capital Corporation Announces Offering of 6.125% Notes due 2023
-
ConvenientMD Receives Significant Investment from Starr Investment Holdings
-
Gladstone Capital Corporation Announces Note Offering
-
Gladstone Capital Corporation Announces Note Offering
-
Advanced Data Protection Firm Baffle Wins Security Current's Security Shark Tank® Chicago
-
William Blair Upgrades Systemax (SYX) to Outperform
-
CyrusOne Reports Third Quarter 2018 Earnings
-
William Blair Starts Celyad SA (CYAD) at Outperform
-
William Blair Downgrades Elevate Credit Inc (ELVt) to Market Perform
-
EnerSys (ENS) Agrees to Acquire the Alpha Technologies Group of Companies in $750M Transaction
-
EnerSys Announces Agreement to Acquire the Alpha Technologies Group of Companies, Creating the Only Complete Power Solution Provider for Broadband, Telecom and Energy Storage Systems
-
EnerSys Announces Agreement to Acquire the Alpha Technologies Group of Companies, Creating the Only Complete Power Solution Provider for Broadband, Telecom and Energy Storage Systems
-
William Blair Starts Guardant Health (GH) at Outperform
-
Robertshaw Acquires CastFutura S.p.A.
-
William Blair Starts Xilinx (XLNX) at Market Perform
-
YETI (YETI) IPO Opens 7% Lower
-
Form D/A William Blair Systematic
-
YETI Holdings, Inc. (YETI) Prices 16M Share IPO at $18/Sh
-
William Blair Starts Silicon Labs (SLAB) at Market Perform
-
YETI Holdings, Inc. Announces Pricing of Initial Public Offering
-
NAIC to Honor Former Illinois Senate President Emil Jones Jr., Ariel's John Rogers and Others at Conference
-
Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option

